Adam Smith: Life in the spotlight. Diabetes in the background.

Hello, it’s Smithy*!

"I was diagnosed with type 1 diabetes at the age of 30. This was a pivotal time for me, as incredibly, it was the exact same year I became a full-time TV presenter. 

Everything changes from diagnosis. Living with diabetes is more than just a physical condition. For years, I also struggled with my mental health whilst navigating all the extra daily decisions of managing type 1.

Fast forward to today and my busy life in the public eye, as a husband, and as a father, has been made so much more manageable thanks to the Omnipod® 5 Automated Insulin Delivery System."


How Omnipod Fits in My Life:

SLEEP

I cannot express the impact it’s had on my sleep. My glucose levels are so much more stable overnight, meaning my sleep has improved dramatically and I’m ready to face whatever is ahead the following day!

BUSY SCHEDULE

It fits seamlessly into my hectic schedule – I don’t have to worry about injecting at stadiums, in the studio or whilst travelling on busy trains. It’s so easy to use.

RAISING AWARENESS

The visibility of wearing my Pod on TV, during major interviews, while hosting events, or just out and about, always starts positive and important conversations about type 1 diabetes.

“Omnipod 5 has given me back a freedom that I thought diabetes had taken from me. I no longer live around diabetes – I live my life alongside it, on my terms.”

My top 3 things about Omnipod 5:

 

  • No more multiple daily injections – it’s discreet, easy to use and great on the go!
  • More headspace – less daily decisions, less diabetes admin.
  • Improved outcomes – personally, my glucose levels have never been better, even though it feels like I’m doing much less work.
Open PEK Box Open PEK Box

Curious to try?

The Pod Experience Kit* is a real-feel, real-size, real-weight demo Pod, without the insulin, so you can: 

  • Experience what it’s like to wear a Pod 
  • See how discreet it can be 
  • Feel the freedom of going tubeless: at home, at work, or on the move 
Start your Omnipod journey
*The Demo Pod is a needle-free, non-functioning Pod. It will not deliver insulin. The Pod Experience Kit does not include a Controller.
Omnipod 5 with Pod (with adhesive) on right and in mmo/L in English Omnipod 5 with Pod (with adhesive) on right and in mmo/L in English
Screen for illustrative purposes only.

More About Omnipod® 5

 

  • The first and only tubeless, waterproof† hybrid closed loop system compatible with leading sensor brands 
  • Automatically adjusts insulin every five minutes1,2 
  • Delivered more than 80% time in range with optimised settings3
3. Sawyer A, et al. Diabetes Technol Ther. 2026. Retrospective RWE of T1D users utilizing optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, and ≥5 bolus/day. Optimized settings: CF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350, Average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). 


Why Omnipod® 5?

icon tubeless pod

TUBELESS FREEDOM No Tubes. No Tangles.

Insulin is delivered via a small, waterproof† Pod that sticks directly to the body for up to 3 days of wear - no need for belt clips, pockets or tubing.

Icon - Brain

AUTOMATED INSULIN DELIVERY Less worry, more living.

Omnipod 5 integrates with your sensor and adjusts insulin every 5 minutes based on current and predicted glucose levels.

shirt icon

DISCREET & COMFORTABLE Wear it, forget it.

Slim, low-profile Pod fits comfortably under clothing and moves with you without the hassle of managing a tubed pump - perfect for sleep, activity, and everyday life.

Icon of trainer

LIVE LIFE UNINTERRUPTED Swim, shower†, sleep, and play.

Unlike tethered pumps that may need to be disconnected for certain activities, Omnipod 5 is designed to stay connected during daily activities.

Request a Pod Experience Kit

Please note that you should speak with your diabetes healthcare provider to assess your suitability for the Omnipod® Systems.

Indicates required field
Which of the following options best describes you?
Are you currently on Omnipod?
Type of Diabetes

Wir möchten, dass Ihr Pod-Erlebnis-Kit zu einer besonderen Erfahrung wird. Deshalb bieten wir zusätzliche Informationen zu Omnipod wie z.B. Webinare mit Produktdemonstrationen, E-Mails und persönlichen Kontakt mit unseren Experten zu unseren Produkten und Dienstleistungen.

Is this a mobile number or is it a home or work number?
Keep typing until you see your address.
Click here to enter your address manually.

Patient Information

Has this person ever used Omnipod before?
Type of Diabetes

Parent Information

Caregiver Information

Wir möchten, dass Ihr Pod-Erlebnis-Kit zu einer besonderen Erfahrung wird. Deshalb bieten wir zusätzliche Informationen zu Omnipod wie z.B. Webinare mit Produktdemonstrationen, E-Mails und persönlichen Kontakt mit unseren Experten zu unseren Produkten und Dienstleistungen.

Is this a mobile number or is it a home or work number?
Keep typing until you see your address.
Click here to enter your address manually.

Individual conditions may vary. Professional medical advice should be sought before use. Personal opinion and not intended as medical advice.

The system requires compatible sensors. A separate prescription is required for the sensor. The sensors are sold separately. Bolus for meals and corrections are still needed. 

† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating.

1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001.

2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001.

3. Sawyer A, et al. Diabetes Technol Ther. 2026. Retrospective RWE of T1D users utilizing optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, and ≥5 bolus/day. Optimized settings: CF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350, Average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L).